Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19

meplazumab - Jiangsu Pacific Meinuoke Biopharmaceutical, Air Force Medical University

http://clinicaltrials.gov/ct2/show/NCT05679479

May 28, 2024